Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00001518 · ClinicalTrials.gov registry record

A Randomized Evaluation of the Effect of Routine Normal Saline Flush Versus Heparinized Saline Solution in Groshong and Groshong PICC Catheters

A clinical trial, sponsored by National Institutes of Health Clinical Center (CC).

Completed
Registry status
132
Enrollment target

NCT00001518 is a clinical trial that has completed, run by National Institutes of Health Clinical Center (CC). The registered enrollment target is 132 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00001518 has completed, sponsored by National Institutes of Health Clinical Center (CC).

COMPLETED
Registry status
132 participants
Enrollment target

Study Summary

The Groshong and Groshong PICC catheters are popular venous access devices because they are maintained with only weekly saline flushes. In a recent study, however, we found an apparent decrease in the rate of withdrawal occlusion in Groshong catheters flushed weekly with heparinized saline. However, a randomized trial is necessary to confirm this impression. In the current study as many as 66 patients will be randomized to each of two treatment arms. The Groshong catheters of one group will be flushed with saline only and the other group with heparinized saline. A comparison will be made between the frequency with which urokinase is used in the two groups to treat withdrawal occlusion during the first three months of catheterization. Groshong catheters using saline flushes will be compared to Groshong catheters using heparinized saline flushes and Groshong PICC catheters using saline flushes will be compared to Groshong PICC catheters using heparinized saline flushes. Data will be analyzed using Fisher's exact test.

Trial Details

FieldValue
Enrollment Target 132 participants
Start Date 1996-01
Est. Completion 2000-11

What the Registry Record Tells You About NCT00001518

The ClinicalTrials.gov registry entry for NCT00001518 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 132 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Institutes of Health Clinical Center (CC), which has 338 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 0 interventions.

NCT00001518 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT00001518 about?

NCT00001518 is a clinical study titled "A Randomized Evaluation of the Effect of Routine Normal Saline Flush Versus Heparinized Saline Solution in Groshong and Groshong PICC Catheters". The Groshong and Groshong PICC catheters are popular venous access devices because they are maintained with only weekly saline flushes. In a recent study, however, we found an apparent decrease in the rate of withdrawal occlusion in Groshong catheters flushed weekly with heparinized saline. However,...

What is the current status of trial NCT00001518?

This trial is currently completed. The enrollment target is 132 participants. The study started on 1996-01. Estimated completion is 2000-11.

Who is sponsoring clinical trial NCT00001518?

This trial is sponsored by National Institutes of Health Clinical Center (CC), which has 338 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.